机构:[1]Department of Radiation Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.[2]Department of Pathology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.[3]Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.[4]Department of Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing, China.[5]Department of Oncology, Sichuan Second Hospital of Traditional Chinese Medicine, Chengdu, China.[6]Nanjing Medical University, Nanjing, China.
第一作者机构:[1]Department of Radiation Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Lu Lin,Xia Lei,Shi Xinhong,et al.Long-term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma[J].Clinical And Translational Medicine.2025,15(6):e70377.doi:10.1002/ctm2.70377.
APA:
Lu Lin,Xia Lei,Shi Xinhong,Dai Yingying,Wu Zipeng...&Chen Cheng.(2025).Long-term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma.Clinical And Translational Medicine,15,(6)
MLA:
Lu Lin,et al."Long-term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma".Clinical And Translational Medicine 15..6(2025):e70377